Indivior Pharmaceuticals, Inc. (INDV)
NASDAQ · Healthcare
Indivior Pharmaceuticals, Inc. Long Term Debt 2022–2025
Indivior Pharmaceuticals, Inc. annual long term debt history from 2023 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Indivior Pharmaceuticals, Inc. long term debt as of December 31, 2025: 290.0M, a 7.94% decrease year-over-year.
- Indivior Pharmaceuticals, Inc. long term debt for 2025 were 290.0M, a 7.94% decrease from 2024.
- Indivior Pharmaceuticals, Inc. long term debt for 2024 were 315.0M, a 32.91% increase from 2023.
- Indivior Pharmaceuticals, Inc. long term debt for 2023 were 237.0M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Indivior Pharmaceuticals, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $290 |
| 2024 | $315 |
| 2023 | $237 |
Indivior Pharmaceuticals, Inc. Long Term Debt — FAQ
Indivior Pharmaceuticals, Inc. (INDV) long term debt over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INDV's long term debt history?
The chart and table above show Indivior Pharmaceuticals, Inc.'s long term debt by year and by quarter, including the growth rate.